Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M529Revenue (TTM) $M138Net Margin (%)-67.3Altman Z-Score-5.2
Enterprise Value $M533EPS (TTM) $-0.7Operating Margin %-59.6Piotroski F-Score4
P/E(ttm)--Beneish M-Score0.5Pre-tax Margin (%)-67.3Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio3.0Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %--Current Ratio3.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-441.2ROA % (ttm)-48.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-2,333.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M145ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with ARRY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARRYKen Fisher 2015-09-30 Buy $4.56 - $7.11
($5.94)
$ 3.65-39%New holding135,695
ARRYFirst Eagle Investment 2011-12-31 Sold Out -0.0024%$1.77 - $2.83
($2.27)
$ 3.6561%Sold Out0
ARRYGeorge Soros 2011-12-31 Sold Out -0.0008%$1.77 - $2.83
($2.28)
$ 3.6560%Sold Out0
ARRYGeorge Soros 2011-09-30 Buy $1.99 - $2.62
($2.24)
$ 3.6563%New holding22,400
ARRYFirst Eagle Investment 2011-06-30 Add$2.06 - $3.21
($2.7)
$ 3.6535%Add 150.00%250,000
ARRYGeorge Soros 2011-06-30 Sold Out $2.06 - $3.21
($2.7)
$ 3.6535%Sold Out0
ARRYFirst Eagle Investment 2011-03-31 Buy $2.7 - $3.29
($3)
$ 3.6522%New holding100,000
ARRYGeorge Soros 2011-03-31 Buy $2.7 - $3.29
($3)
$ 3.6522%New holding14,400
ARRYFirst Eagle Investment 2010-09-30 Sold Out -0.01%$2.67 - $3.44
($3.02)
$ 3.6521%Sold Out0
ARRYFirst Eagle Investment 2010-06-30 Reduce-0.01%$2.66 - $4.02
($3.41)
$ 3.657%Reduce -54.96%450,000
ARRYFirst Eagle Investment 2009-12-31 Add0.01%$1.72 - $2.81
($2.2)
$ 3.6566%Add 62.96%999,132
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARRY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ARRY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Redmile Group, LLC10% Owner 2016-09-15Sell400,000$3.54.29view
Redmile Group, LLC10% Owner 2016-09-15Buy400,000$3.513.99view
Redmile Group, LLC10% Owner 2016-01-20Buy300,000$3.1914.42view
Redmile Group, LLC10% Owner 2016-01-12Buy75,000$3.61.39view
Redmile Group, LLC10% Owner 2016-01-11Buy925,000$3.67-0.54view
Redmile Group, LLC10% Owner 2015-10-01Buy782,592$4.58-20.31view
Redmile Group, LLC10% Owner 2015-10-01Buy600,140$4.58-20.31view
Redmile Group, LLC10% Owner 2015-08-26Buy49,900$5.48-33.39view
Redmile Group, LLC10% Owner 2015-08-25Buy790,000$5.38-32.16view
Redmile Group, LLC10% Owner 2015-08-12Buy532,500$5.88-37.93view

Quarterly/Annual Reports about ARRY:

News about ARRY:

Articles On GuruFocus.com
Screen: Stocks With Estimated Revenue Up 5% - January Jan 18 2016 
Insider Buys Round-up: Tenet Healthcare and Sprint Corp Aug 14 2015 
Novartis Gets FTC Nod To Buyout Glaxo Smithkline’s Cancer Drugs Feb 25 2015 
Can These Three BioTech Companies Make It Big? Feb 20 2015 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,310 Shares Mar 16 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,403 Shares Feb 11 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,272 Shares Jan 13 2011 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,256 Shares Dec 10 2010 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,220 Shares Nov 12 2010 
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,225 Shares Oct 13 2010 

More From Other Websites
5 Stocks Insiders Love Right Now Sep 21 2016
Array BioPharma, Inc. – Value Analysis (NASDAQ:ARRY) : September 21, 2016 Sep 21 2016
Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : September... Sep 20 2016
10 Analyst Stock Picks Under $10 for Massive Upside Sep 18 2016
Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference Sep 17 2016
Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference Sep 17 2016
Array BioPharma Announces FDA Acceptance of Binimetinib NDA for Patients with Advanced NRAS-Mutant... Sep 17 2016
Array Secures SPA Agreement With FDA for Colorectal Cancer Trial (ARRY) Sep 14 2016
Why Sarepta, Glu Mobile, Harmony Gold and 2 Other Stocks Are On The Move Today Sep 14 2016
Key FDA Decisions and Trial Results Coming in the Next 2 Months Sep 14 2016
Array BioPharma Announces Phase 3 BEACON CRC SPA Agreement with FDA Sep 14 2016
ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 14 2016
Array BioPharma Announces Phase 3 BEACON CRC SPA Agreement with FDA Sep 14 2016
Why Array Biopharma May Become a Winner (ARRY) Sep 12 2016
How To Approach Momentum Trading Like A Pro Sep 11 2016
Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : September... Sep 09 2016
Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference Sep 06 2016
Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference Sep 06 2016
5 Speculative Biotech Analyst Stocks Under $10 With Massive Upside Sep 04 2016
ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Sep 02 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)